Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Herrera S, de Vega WC, Ashbrook D, Vernon SD, McGowan PO.

Epigenetics. 2018;13(12):1174-1190. doi: 10.1080/15592294.2018.1549769. Epub 2018 Dec 5.

PMID:
30516085
2.

C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Uhde M, Indart A, Fallon BA, Wormser GP, Marques AR, Vernon SD, Alaedini A.

Clin Infect Dis. 2018 Sep 28;67(8):1309-1310. doi: 10.1093/cid/ciy299. No abstract available.

3.

Exploring the Diagnostic Potential of Immune Biomarker Co-expression in Gulf War Illness.

Broderick G, Fletcher MA, Gallagher M, Barnes Z, Vernon SD, Klimas NG.

Methods Mol Biol. 2018;1781:101-120. doi: 10.1007/978-1-4939-7828-1_7.

PMID:
29705845
4.

Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome.

de Vega WC, Erdman L, Vernon SD, Goldenberg A, McGowan PO.

Epigenomics. 2018 May;10(5):539-557. doi: 10.2217/epi-2017-0150. Epub 2018 Apr 25.

PMID:
29692205
5.

Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Uhde M, Indart AC, Yu XB, Jang SS, De Giorgio R, Green PHR, Volta U, Vernon SD, Alaedini A.

Gut. 2019 Feb;68(2):377-378. doi: 10.1136/gutjnl-2018-316133. Epub 2018 Mar 17. No abstract available.

6.

Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

de Vega WC, Herrera S, Vernon SD, McGowan PO.

BMC Med Genomics. 2017 Feb 23;10(1):11. doi: 10.1186/s12920-017-0248-3.

7.

Neural consequences of post-exertion malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Cook DB, Light AR, Light KC, Broderick G, Shields MR, Dougherty RJ, Meyer JD, VanRiper S, Stegner AJ, Ellingson LD, Vernon SD.

Brain Behav Immun. 2017 May;62:87-99. doi: 10.1016/j.bbi.2017.02.009. Epub 2017 Feb 17.

8.

The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Murdock KW, Wang XS, Shi Q, Cleeland CS, Fagundes CP, Vernon SD.

Qual Life Res. 2017 Apr;26(4):913-921. doi: 10.1007/s11136-016-1406-3. Epub 2016 Sep 6.

9.

Tracking post-infectious fatigue in clinic using routine Lab tests.

Harvey JM, Broderick G, Bowie A, Barnes ZM, Katz BZ, O'Gorman MRG, Vernon SD, Fletcher MA, Klimas NG, Taylor R.

BMC Pediatr. 2016 Apr 26;16:54. doi: 10.1186/s12887-016-0596-8.

10.

Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research.

Edwards KA, Terry SF, Gold D, Horn EJ, Schwartz M, Stuart M, Vernon SD.

Biopreserv Biobank. 2016 Aug;14(4):314-8. doi: 10.1089/bio.2015.0053. Epub 2016 Apr 8.

11.

Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Shukla SK, Cook D, Meyer J, Vernon SD, Le T, Clevidence D, Robertson CE, Schrodi SJ, Yale S, Frank DN.

PLoS One. 2015 Dec 18;10(12):e0145453. doi: 10.1371/journal.pone.0145453. eCollection 2015.

12.

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.

Landi A, Broadhurst D, Vernon SD, Tyrrell DL, Houghton M.

Cytokine. 2016 Feb;78:27-36. doi: 10.1016/j.cyto.2015.11.018. Epub 2015 Nov 28.

13.

Chronic Fatigue Syndrome versus Systemic Exertion Intolerance Disease.

Jason LA, Sunnquist M, Brown A, Newton JL, Strand EB, Vernon SD.

Fatigue. 2015 Jul;3(3):127-141.

14.

Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome.

Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung'u T, Ruxrungtham K, Sanchez J, Brander C, Chung RT, O'Connor KC, Walker B, Larman HB, Elledge SJ.

Science. 2015 Jun 5;348(6239):aaa0698. doi: 10.1126/science.aaa0698.

15.

Chronic Fatigue Syndrome and Myalgic Encephalomyelitis: Toward An Empirical Case Definition.

Jason LA, Kot B, Sunnquist M, Brown A, Evans M, Jantke R, Williams Y, Furst J, Vernon SD.

Health Psychol Behav Med. 2015;3(1):82-93.

16.

Anti-neural antibody response in patients with post-treatment Lyme disease symptoms versus those with myalgic encephalomyelitis/chronic fatigue syndrome.

Ajamian M, Cooperstock M, Wormser GP, Vernon SD, Alaedini A.

Brain Behav Immun. 2015 Aug;48:354-5. doi: 10.1016/j.bbi.2015.04.006. Epub 2015 Apr 10. No abstract available.

17.

DNA methylation modifications associated with chronic fatigue syndrome.

de Vega WC, Vernon SD, McGowan PO.

PLoS One. 2014 Aug 11;9(8):e104757. doi: 10.1371/journal.pone.0104757. eCollection 2014.

18.

No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank.

Irlbeck DM, Vernon SD, McCleary KK, Bateman L, Klimas NG, Lapp CW, Peterson DL, Brown JR, Remlinger KS, Wilfret DA, Gerondelis P.

BMC Res Notes. 2014 Aug 4;7:461. doi: 10.1186/1756-0500-7-461.

19.

Comparing and Contrasting Consensus versus Empirical Domains.

Jason LA, Kot B, Sunnquist M, Brown A, Reed J, Furst J, Newton JL, Strand EB, Vernon SD.

Fatigue. 2014 Apr 1;3(2):63-74. Epub 2015 Aug 26.

20.

Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis.

Jason LA, Sunnquist M, Brown A, Evans M, Vernon SD, Furst J, Simonis V.

Fatigue. 2014 Jan 1;2(1):40-56.

Supplemental Content

Loading ...
Support Center